title: Does normalizing PSA after successful treatment of chronic prostatitis with high PSA value exclude prostatic biopsy?
abstract: OBJECTIVE
  Evaluate male patients with diagnosed chronic prostatitis, elevated serum prostate-specific antigen (PSA) to find out whether medical treatment with antibiotics and anti-inflammatory drugs can lower serum PSA, and consequently decrease the prostate cancer detection rate in patients with post-treatment PSA<4 ng/mL.
  
  
  METHODS
  This prospective study evaluated 142 male patients aged 40-73 years whose presented with elevated serum PSA>4 ng/mL and were consequently diagnosed with chronic prostatitis as expressed prostatic excretions examination revealed more than 10 white blood cells per high power field. The Patients underwent treatment with antibiotics and nonsteroidal anti-inflammatory agents for 6-weeks. Subsequently, all patients are Followed-up by serum PSA and performed transrectal ultrasonography-guided prostate biopsy within 2 months of treatment.
  
  
  RESULTS
  Mean patient age was (54.4±13.5) years. The mean PSA pretreatment was (8.11±3.7) ng/mL and after treatment, the mean PSA denoted a significant decrease to (4.7±3.5) ng/mL (P=0.002). The percent of changes in mean PSA was 41.9%. Prostatic biopsy after treatment showed that, cancer prostate in 31 patients (21.8%), chronic prostatitis in 71 patients (50.7%), chronic prostatitis plus benign prostatic hyperplasia (BPH) in 31 (21.8%) and BPH in 9 patients (6.3%) With regard to PSA values, cancer prostate patients were 3/25 (12%) if PSA<2.5 ng/mL, 6/47 (12.7%) if 4.0>PSA≥2.5 and 21/70 (30%) if PSA≥4.0. The numbers of cancer prostate detected patients were 30 (21.1%).
  
  
  CONCLUSIONS
  Chronic prostatitis is one of the causes that elevate serum PSA levels. Treatment of chronic prostatitis with elevated PSA by antibiotics and anti-inflammatory agents can decrease the elevated PSA to the normal levels. Nevertheless, the opportunities of potential prostate cancer still exist in patients with a decreased PSA level even also if PSA<2.5 ng/mL.
authors.affiliation: 1 Urology Department, Faculty of medicine, October 6 University, 2 Radiology Department, October 6 University; 3 Clinical Pathology Department, National research Center, Cairo, Egypt.
authors.forename: Sherif
authors.initials: S
authors.lastname: Azab
authors.affiliation: 1 Urology Department, Faculty of medicine, October 6 University, 2 Radiology Department, October 6 University; 3 Clinical Pathology Department, National research Center, Cairo, Egypt.
authors.forename: Ayman
authors.initials: A
authors.lastname: Osama
authors.affiliation: 1 Urology Department, Faculty of medicine, October 6 University, 2 Radiology Department, October 6 University; 3 Clinical Pathology Department, National research Center, Cairo, Egypt.
authors.forename: Mona
authors.initials: M
authors.lastname: Rafaat
keywords: Prostate-specific antigen; biopsy; cancer prostate; prostatitis
references.citation: N Engl J Med. 2004 May 27;350(22):2239-46
references.pmid: 15163773
references.citation: J Urol. 2000 Nov;164(5):1550-3
references.pmid: 11025702
references.citation: Urology. 2000 Nov 1;56(5):817-22
references.pmid: 11068309
references.citation: J Urol. 2002 Apr;167(4):1723-6
references.pmid: 11912396
references.citation: Urology. 2005 Mar;65(3):549-53
references.pmid: 15780374
references.citation: Urology. 1989 Jun;33(6):465
references.pmid: 2471345
references.citation: J Urol. 1995 Aug;154(2 Pt 1):407-13
references.pmid: 7541857
references.citation: Eur Urol. 1996;30(1):24-7
references.pmid: 8854063
references.citation: J Urol. 2009 Jan;181(1):128-32
references.pmid: 19012907
references.citation: J Urol. 2010 Mar;183(3):940-4
references.pmid: 20089269
references.citation: J Med Liban. 2002 Jan-Apr;50(1-2):23-5
references.pmid: 12841309
references.citation: Int Urol Nephrol. 2007;39(3):859-63
references.pmid: 17111077
references.citation: J Urol. 2003 Feb;169(2):589-91
references.pmid: 12544313
references.citation: N Engl J Med. 2003 Jul 24;349(4):366-81
references.pmid: 12878745
references.citation: Urology. 2000 Jun;55(6):791-5
references.pmid: 10840078
references.citation: Eur Urol. 2000 May;37(5):537-40
references.pmid: 10765091
references.citation: Prostate. 1994 Aug;25(2):91-6
references.pmid: 7518599
references.citation: Urol Int. 2006;76(1):20-6
references.pmid: 16401916
references.citation: Eur Urol. 2004 Dec;46(6):760-4
references.pmid: 15548444